Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Substance abuse treatment in an urban HIV clinic

Who enrolls and what are the benefits

Bibliographic Data

ID19442877
AuthorsMaria Pisu (University of Alabama, corresponding author), Gretchen Cloud (University of Alabama), Gretchen A Cloud (University of Alabama at Birmingham), Shamly Austin (0000-0003-1307-9849, University of Alabama), James L Raper (0000-0002-3242-4911, University of Alabama), Katharine E Stewart (0000-0002-2406-8638, University of Arkansas for Medical Sciences), Joseph E Schumacher (University of Alabama)
Year2010
Volume22
Issue3
Pages348-354
Publication date2010-03-01
Open AccessNo
TypeARTICLE
VenueAIDS Care (JOURNAL)
Journal identifiersISSN: 0954-0121 • E-ISSN: 1360-0451
PublisherInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09540120903193658
PMID20390515
OpenAlexW2008308038
LanguageEN
Citations received1
References cited13

Substance abuse treatment (SAT) is important for HIV medical care. Characteristics of those who choose SAT and effects of SAT on HIV clinical outcomes are not understood. We compared patients who enrolled and did not enroll in a SAT program offered within an HIV clinic, and evaluated the effect of SAT on CD4 T-cell counts and HIV plasma viral load (VL). Subjects were assessed and invited to enroll in SAT. Enrollees chose to receive psychological and psychiatric treatment, or motivational enhancement and relapse prevention, or residential SAT. We used logistic regressions to determine factors associated with enrollment (age, race, sex, HIV transmission risk factors, CD4 T-cell counts, and VL at assessment). A two-period (assessment and six months after SAT) data analysis was used to analyze the effect of SAT on CD4 T-cell count and log VL controlling for changes in HIV therapy. We find that, compared to Decliners (N=76), Enrollees (N=78) were more likely to be females (29.5% vs. 6.6%, OR=5.32, 95% CI 1.61-17.6), and to report injection drug use (IDU) as the HIV transmission risk factor (23.1% vs. 9.2%, OR=3.92, CI 1.38-11.1). Age (37.2 vs. 38.4), CD4 T-cell count (377.3 vs. 409.2), and log VL (3.21 vs. 2.99) at assessment were similar across the two groups (p>0.05). After six months, Enrollees and Decliners' CD4 T-cell counts increased and log VL decreased. SAT did not affect the change in CD4 T-cell count (p=0.51) or log VL (p=0.73). Similar results were found for patients with CD4 T-cell count < or =350 at assessment. In this small sample of HIV-infected patients with a limited follow-up period, women were more likely to enroll in SAT than men, and SAT reached those who needed it, e.g., IDUs. We did not find an effect of SAT on HIV clinical outcomes

Logistic regression · Psychiatry · Substance abuse · Viral load · HIV Research and Treatment · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Immunology · Internal Medicine

  • Substance Use

    Open Access•Adam Gonzalez, Jennifer Barinas et al.•Current HIV/AIDS Reports•2011

  • The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States

    Frank H Galván, Eric G Bing et al.•Journal of Studies on Alcohol and…•2002

  • Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

    Gregory M Lucas, Kelly A Gebo et al.•AIDS•2002

  • Do Mechanisms that Link Addiction Treatment Patients to Primary Care Influence Subsequent Utilization of Emergency and Hospital Care

    Peter D Friedmann, James C Hendrickson et al.•Medical Care•2006

Citations per year0.07
Citation span2011 - 2011 (1)
Highly citedNo

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae